(Q41316319)

29 September 2017

1 reference

title

Lipoprotein disorders in women: which women are the best candidates for hormone replacement therapy? (English)

1 reference

29 September 2017

S L Plushner

1

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

Annals of Pharmacotherapy

29 September 2017

published in

1 reference

29 September 2017

volume

31

1 reference

29 September 2017

issue

1

1 reference

29 September 2017

page(s)

98-107

1 reference

Hormone therapy to prevent disease and prolong life in postmenopausal women

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100116

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100116

Lp(a) lipoprotein: relationship to cardiovascular disease risk factors, exercise, and estrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100116

Estrogen and coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100116

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100116

Menopause and the risk of coronary heart disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100116

Menopause and coronary heart disease. The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100116

Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100116

Natural oestrogen as an effective treatment for type-II hyperlipoproteinaemia in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100116

Effects of continuous combined hormone-replacement therapy on lipid levels in hypercholesterolemic postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100116

Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100116

Effects of estrogen dose and smoking on lipid and lipoprotein levels in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100116

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100116

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100116

Combined Estrogen and Progestin Hormone Replacement Therapy in Relation to Risk of Breast Cancer in Middle-aged Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100116

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100116

10.1177/106002809703100116

21 January 2018

Identifiers

DOI

1 reference

29 September 2017

1 reference